Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and - resistant bacteria by a semisynthetic glycopeptide antibiotic

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2356-2362

  Allen, Norris E ^a   Hobbs Jr , Joe N ^a   Nicas, Thalia I ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROORIENTICIN A; LY 191145; PEPTIDOGLYCAN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BIOSYNTHESIS; DRUG EFFECT; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029797308     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2356     Document Type: Article

References (46)

1. Allen, N. E., J. N. Hobbs, Jr., and W. E. Alborn, Jr. 1987. Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032. Antimicrob. Agents Chemother. 31:1093-1099.
2. Allen, N. E., J. N. Hobbs, Jr., J. M. Richardson, and R. M. Riggin. 1992. Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium. FEMS Microbiol. Lett. 98:109-116.
3. Allen, N. E., D. L. LeTourneau, and J. N. Hobbs, Jr. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-Ala-D-Ala and D-Ala-D-Lac ligands. Submitted for publication.
4. Anderson, J. S., M. Matsuhashi, M. A. Haskin, and J. L. Strominger. 1965. Lipid-phosphoacetylmuramyl-pentapeptide and lipid-phosphodisaccharide-pentapeptide: presumed membrane transport intermediates in cell wall synthesis. Proc. Natl. Acad. Sci. USA 53:881-889.
5. Anderson, J. S., M. Matsuhashi, M. A. Haskin, and J. L. Strominger. 1967. Biosynthesis of the peptidoglycan of bacterial cell walls. II. Phospholipid carriers in the reaction sequence. J. Biol. Chem. 242:3180-3190.
6. Anderson, J. S., P. M. Meadow, M. A. Haskin, and J. L. Strominger. 1966. Biosynthesis of the peptidoglycan of bacterial cell walls. I. Utilization of uridine diphosphate acetylmuramyl pentapeptide and uridine diphosphate acetylglucosamine for peptidoglycan synthesis by particulate enzymes from Staphylococcus aureus and Micrococcus lysodeikticus. Arch. Biochem. Biophys. 116:487-515.
7. Arthur, M., and P. Courvalin. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563-1571.
8. Arthur, M., F. Depardieu, H. A. Snaith, P. E. Reynolds, and P. Courvalin. 1994. Contribution of VanY D, D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors. Antimicrob. Agents Chemother. 38:1899-1903.
9. Barna, J. C. J., and D. H. Williams. 1984. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu. Rev. Microbiol. 38:339-357.
10. Beauregard, D. A., D. H. Williams, M. N. Gwynn, and D. J. C. Knowles. 1995. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob. Agents Chemother. 39:781-785.
11. Bugg, T. D. H., S. Dutka-Malen, M. Arthur, P. Courvalin, and D. T. Walsh. 1991. Identification of vancomycin resistance protein vanA as a D-alanine: D-alanine ligase of altered substrate specificity. Biochemistry 30:2017-2021.
12. Bugg, T. D. H., G. D. Wright, S. Dutka-Malen, M. Arthur, P. Courvalin, and C. T. Walsh. 1991. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins vanH and vanA. Biochemistry 30:10408-10415.
13. Bupp, K., and J. van Heijenoort. 1993. The final step of peptidoglycan subunit assembly in Escherichia coli occurs in the cytoplasm. J. Bacteriol. 175:1841-1843.
14. Carpenter, C. V., S. Goyer, and F. C. Neuhaus. 1976. Steric effects on penicillin sensitive peptidoglycan synthesis in a membrane-wall system from Gaffkya homari. Biochemistry 15:3146-3152.
15. Cooper, R. D. G., N. J. Snyder, M. J. Zweifel, M. A. Staszak, S. C. Wilkie, T. I. Nicas, D. L. Mullen, T. F. Butler, M. J. Rodriguez, B. E. Huff, and R. C. Thompson. 1996. Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity. J. Antibiot. 49:575-581.
16. Hammes, W. P., and F. C. Neuhaus. 1974. Biosynthesis of peptidoglycan in Gaffkya homari: role of the peptide subunit of uridine diphosphate-N-acetylmuramyl-pentapeptide. J. Bacteriol. 120:210-218.
17. Hammes, W. P., and F. C. Neuhaus. 1974. On the mechanism of action of vancomycin: inhibition of peptidoglycan synthesis in Gaffkya homari. Antimicrob. Agents Chemother. 6:722-728.
18. Handwerger, S., M. J. Pucci, K. J. Volk, J. Liu, and M. S. Lee. 1992. The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate. J. Bacteriol. 174:5982-5984.
19. Hobbs, J. N., Jr. 1996. Unpublished results.
20. Kang, S. L., and M. J. Rybak. 1995. Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and staphylococcus-infected fibrin clots. Antimicrob. Agents Chemother. 39:2832-2834.
21. Leclercq, R., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161.
22. LeTourneau, D. L., and N. E. Allen. 1996. Unpublished results.
23. Lugtenberg, E. J., and P. B. DeHaan. 1971. A simple method for following the fate of alanine-containing components in murein synthesis in Escherichia coli. Antonie Leeuwenhoek J. Microbiol. Serol. 37:537-552.
24. Matsuhashi, M., C. P. Dietrich, and J. L. Strominger. 1967. Biosynthesis of the peptidoglycan of bacterial cell walls. III. The role of soluble ribonucleic acid and of lipid intermediates in glycine incorporporation in Staphylococcus aureus. J. Biol. Chem. 242:3191-3206.
25. Messer, J., and P. E. Reynolds. 1992. Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci. FEMS Microbiol. Lett. 94:195-200.
26. Mirelman, D., Y. Yashouv-Gan, and U. Schwartz. 1976. Peptidoglycan biosynthesis in a thermosensitive division mutant of Escherichia coli. Biochemistry 15:1781-1790.
27. Nagarajan, R. 1993. Structure-activity relationships of vancomycin-type glycopeptide antibiotics. J. Antibiot. 46:1181-1195.
28. Nicas, T. I., and N. E. Allen. 1994. Resistance and mode of action, p. 219-241. In R. Nagarajan (ed.), Glycopeptide antibiotics. Marcel Dekker, New York.
29. Nicas, T. I., D. L. Mullen, J. E. Flokowitsch, D. A. Preston, N. J. Snyder, R. E. Stratford, and R. D. G. Cooper. 1995. Activity of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrob. Agents Chemother. 39:2585-2587.
30. Nicas, T. I., C. Y. E. Wu, J. N. Hobbs, Jr., D. A. Preston, and N. E. Allen. 1989. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob. Agents Chemother. 33:1121-1124.
31. Nieto, M., R. Perkins, and P. E. Reynolds. 1972. Reversal by a specific peptide (diacetyl-ag-L-diaminobutyryl-D-alanyl-D-alanine) of vancomycin inhibition in intact bacteria and cell-free preparations. Biochem. J. 126:139-149.
32. Oka, T. 1976. Mode of action of penicillins in vivo and in vitro in Bacillus megaterium. Antimicrob. Agents Chemother. 10:579-591.
33. Perkins, H. R. 1982. Vancomycin and related antibiotics. Pharmacol. Ther. 16:181-197.
34. Perkins, H. R., and M. Nieto. 1970. The preparation of iodinated vancomycin and its distribution in bacteria treated with the antibiotic. Biochem. J. 116:83-92.
35. Perkins, H. R., and M. Nieto. 1974. The chemical basis for the action of the vancomycin group of antibiotics. Ann. N. Y. Acad. Sci. 235:348-363.
36. Popieniek, P. H., and R. F. Pratt. 1987. A fluorescent ligand for binding studies with glycopeptide antibiotics of the vancomycin class. Anal. Biochem. 165:108-113.
37. Reynolds, P. 1961. Studies on the mode of action of vancomycin. Biochim. Biophys. Acta 52:403-405.
38. Reynolds, P. E. 1971. Peptidoglycan synthesis in bacilli. I. Effect of temperature on the in vitro system from Bacillus megaterium and Bacillus stearothermophilus. Biochim. Biophys. Acta 237:239-254.
39. Reynolds, P. E. 1971. Peptidoglycan synthesis in bacilli. II. Characteristics of protoplast membrane preparations. Biochim. Biophys. Acta 237:255-272.
40. Reynolds, P. E. 1989. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8:943-950.
41. Reynolds, P. E., F. Depardieu, S. Dutka-Malen, M. Arthur, and P. Courvalin. 1994. Glycopeptide resistance mediated by enterococcal transposon Tn 1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol. Microbiol. 13:1065-1070.
42. Somner, E. A., and P. E. Reynolds. 1990. Inhibition of peptidoglycan biosynthesis by ramoplanin. Antimicrob. Agents Chemother. 34:413-419.
43. Uttley, A. H. C., C. H. Collins, J. Naidoo, and R. C. George. 1988. Vancomycin-resistant enterococci. Lancet i:57-58.
44. Walsh, C. T. 1993. Vancomycin resistance: decoding the molecular logic. Science 261:308-309.
45. Williams, D. H., and J. P. Waltho. 1988. Molecular basis of the activity of antibiotics of the vancomycin group. Biochem. Pharmacol. 37:133-141.
46. Wu, Z., G. D. Wright, and C. T. Walsh. 1995. Overexpression, purification, and characterization of vanX, a D-,D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147. Biochemistry 34:2455-2463.